Atea Pharmaceuticals Statistics
NASDAQ: AVIRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.20+0.19 (+3.79%)
Market open · Delayed 15 min · as of Oct 8, 2:17 PM ET
Atea Pharmaceuticals by the numbers
Atea Pharmaceuticals has a market capitalization of $417.1 million based on 80.20M shares outstanding. With trailing EPS of $-2.09, Atea Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.6% below its 50-day average and 7.3% above its 200-day average.
Average daily trading volume is 298.38K shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVIR valuation vs. peer median
| Metric | AVIR | Peer median | Difference |
|---|---|---|---|
| Market cap | $417.06M | $433.79M | -4% |
| Avg. volume | 298.38K | 710.28K | -58% |
Peer median across 8 companies: DMAC, GALT, IRD, RZLT, KMDA, ARCT, PRTA, SPRY.
Valuation
- Market cap
- $417.06M
- EPS (TTM)
- $-2.09
- Shares outstanding
- 80.20M
Price and trading
- Previous close
- 5.01
- Open
- 5.00
- Day range
- 4.91 – 5.20
- 52-week range
- 2.87 – 6.45
- 52-week change
- +68.69%
- Beta
- —
- Volume
- 110.94K
- Average volume
- 298.38K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 417.06M
- Forward Pe
- -3.51
- Eps
- -2.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.45
- Week52 Low
- 2.87
- Avg Volume
- 298.38K
- Shares Outstanding
- 80.20M
- Ma50
- 5.23
- Ma200
- 4.85
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -19.38%
- Pct From52w Low
- 81.18%